Annual Report & ACCOUNTS for the year ended 30 June 2014

HYR 2014

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.

Our Strategy

To continue to develop our position as an international, high margin, cash generative, specialist veterinary pharmaceuticals and related products business with a clear focus on key therapeutic areas: dermatology, ophthalmology, equine medicine, anaesthesia and analgesia, endocrinology, cardiovascular disease, food producing animal antimicrobials and pet diets through:

Pipeline
Delivery

Pipeline Delivery

Portfolio
Focus

Portfolio Focus

Geographical
Expansion

Geographical Expansion

Acquisition

Acquisition

Investor Website

We maintain a corporate website at www.dechra.com containing a wide range of information of interest to both institutional and private investors including:

  • Latest news and press releases
  • Annual reports and investor presentations

Look Out For These Icons

Find out more about a specific topic

View further content on our website: www.dechra.com

Forward-Looking Statements: This document contains certain forward-looking statements. The forward-looking statements reflect the knowledge and information available to the Company during preparation and up to the publication of this document. By their very nature, these statements depend upon circumstances and relate to events that may occur in the future and thereby involving a degree of uncertainty. Therefore, nothing in this document should be construed as a profit forecast by the Company.